Marieke Vermeersch - Galapagos Head Communication

GLPG Stock  USD 29.63  0.08  0.27%   

Insider

Marieke Vermeersch is Head Communication of Galapagos NV ADR
Address Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800
Phone32 1 534 29 00
Webhttps://www.glpg.com

Galapagos Management Efficiency

The company has return on total asset (ROA) of (0.0138) % which means that it has lost $0.0138 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0113 %, meaning that it created $0.0113 on every $100 dollars invested by stockholders. Galapagos' management efficiency ratios could be used to measure how well Galapagos manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Galapagos' Return On Equity is most likely to increase slightly in the upcoming years. At this time, Galapagos' Total Current Assets are most likely to increase significantly in the upcoming years. The Galapagos' current Intangible Assets is estimated to increase to about 134.3 M, while Intangibles To Total Assets are projected to decrease to 0.04.
The company currently holds 9.6 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Galapagos NV ADR has a current ratio of 8.07, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Galapagos until it has trouble settling it off, either with new capital or with free cash flow. So, Galapagos' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Galapagos NV ADR sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Galapagos to invest in growth at high rates of return. When we think about Galapagos' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Christoph SchellHP Inc
48
Moshe OrensteinNayax
47
Paul CPAGCM Grosvenor
N/A
Tuan TranHP Inc
56
Kristen LudgateHP Inc
61
Christopher CFAPfizer Inc
N/A
Michael GalaiNayax
58
Bruce BroussardHP Inc
58
CPA CPAGCM Grosvenor
52
Didier DeltortHP Inc
53
Claire BramleyHP Inc
43
Greg BaxterHP Inc
N/A
Vikrant BatraHP Inc
N/A
Judith MiscikHP Inc
62
Gordon LohPfizer Inc
N/A
Frederick JDGCM Grosvenor
44
Kim RuckerHP Inc
54
William CarapezziPfizer Inc
63
Lilly FarahnakianGCM Grosvenor
N/A
Yair NechmadNayax
63
Tami ErelNayax
49
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium. Galapagos operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1344 people. Galapagos NV ADR (GLPG) is traded on NASDAQ Exchange in USA. It is located in Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800 and employs 1,123 people. Galapagos is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Galapagos NV ADR Leadership Team

Elected by the shareholders, the Galapagos' board of directors comprises two types of representatives: Galapagos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Galapagos. The board's role is to monitor Galapagos' management team and ensure that shareholders' interests are well served. Galapagos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Galapagos' outside directors are responsible for providing unbiased perspectives on the board's policies.
Andre Hoekema, Sr. VP of Corporate Devel.
John Montana, Managing Argenta
Walid AbiSaab, Member of the Executive Committee, Chief Medical Officer
Marieke Vermeersch, Head Communication
Ellen Aar, Head Development
Dirk Naeyer, Head Operations
Annelies Missotten, Executive Officer
Alice Dietrich, Head Affairs
Philippe Alen, Senior Development
Elizabeth Goodwin, VP Corporate Communications & Investor Relations
Michele MBA, Head Commercial
Chantal Tasset, Head Devel
Thad Huston, CFO COO
Sofie Gijsel, Head Relations
MBA MBA, COO Pres
Valeria Cnossen, Executive Counsel
PharmD Raboisson, Head VP

Galapagos Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Galapagos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

When determining whether Galapagos NV ADR is a strong investment it is important to analyze Galapagos' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Galapagos' future performance. For an informed investment choice regarding Galapagos Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Galapagos NV ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Galapagos Stock analysis

When running Galapagos' price analysis, check to measure Galapagos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galapagos is operating at the current time. Most of Galapagos' value examination focuses on studying past and present price action to predict the probability of Galapagos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galapagos' price. Additionally, you may evaluate how the addition of Galapagos to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Transaction History
View history of all your transactions and understand their impact on performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Galapagos' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Galapagos. If investors know Galapagos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Galapagos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.914
Earnings Share
0.51
Revenue Per Share
0.1852
Quarterly Revenue Growth
(0.65)
Return On Assets
(0.01)
The market value of Galapagos NV ADR is measured differently than its book value, which is the value of Galapagos that is recorded on the company's balance sheet. Investors also form their own opinion of Galapagos' value that differs from its market value or its book value, called intrinsic value, which is Galapagos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Galapagos' market value can be influenced by many factors that don't directly affect Galapagos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Galapagos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Galapagos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Galapagos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.